ResolutionBio

We are enabling diagnostics 2.0 through proprietary NGS technologies.

[ResolutionBio @ResBioscience]

Very proud of our work to demonstrate clinical utility of our ctDx Lung assay with @MSKCC_OncoNotes and Northern Cancer Institute.

https://t.co/FQr6Sfwc9A

[ResolutionBio @ResBioscience]

Thanks, Geoff!

[Geoff Oxnard MD @geoff_oxnard]

Interesting #liquidbiopsy option: NSCLC patients can soon get the @ResBioscience plasma NGS assay at @LABCORP. It's a quality NSCLC panel, especially for fusion detection in ctDNA. https://t.co/2wnGlW4gBo

[Geoff Oxnard MD @geoff_oxnard]

Trust your favorite liquid biopsy assay? Our @DanaFarber @DCcloudy data comparing 2 hybrid capture plasma NGS assays finds what many suspected - targetable fusions are being missed. Fortunately, assays are constantly improving, as they should be! https://t.co/v45ifavPwW

[David S. Hong MD @DavidHongMD]

This has been our experience with NTRK fusions

[ResolutionBio @ResBioscience]

Learn how DFCI detected more fusions with our #liquidbiopsy @ #AACR2019 this morning @8AM Section 19 abstract 1374/13) https://t.co/VvSBIFdojB

[ResolutionBio @ResBioscience]

Check out my latest article: It's response, stupid https://t.co/1lBO1qlCmQ via @LinkedIn

[ResolutionBio @ResBioscience]

Great blog post about our prospective #NSCLC clinical utility study with our #liquidbiopsy technology. https://t.co/oHWoquETuw

[Gʀᴇɢᴏʀʏ Rɪᴇʟʏ @RielyMD]

My @sloan_kettering colleagues poster on use of @ResBioscience in patients with NSCLC, quick, good concordance #ASCO17

[ResolutionBio @ResBioscience]

Dr Bazhenova presenting brigatinib ALK #liquidbiopsy at #ASCO2O17

[ResolutionBio @ResBioscience]

Dr Iams at the poster on longitudinal #liquidbiopsy in #SCLC with t-cells #ASCO17

[ResolutionBio @ResBioscience]

#liquidbiospy clinical utility study with our collaborators at @sloan_kettering and the Royal North shore @ASCO Abstract#11536 Hall A 1:15PM

[ResolutionBio @ResBioscience]

Coming to @ASCO? Interested in @liquidbiopsy, @SCLC and TCRs with our collaborators at Northwestern and @VanderbiltU Abstract#8571

[ResolutionBio @ResBioscience]

Very happy to announce the publication of our paper on cell-free DNA with our partners @PlasmaLab https://t.co/scYT0rTg9e

[ResolutionBio @ResBioscience]

Coming to ASCO? Check out our ALK longitudinal data: https://t.co/VbqmA1LPM3

[ResolutionBio @ResBioscience]

Our cfDNA platform was covered in @GENbio! https://t.co/PgE1tNiRrs

[Christian Burks @scienega]

"Rising #LiquidBiopsy Tide Lifts Cancer Dx" https://t.co/Piu0X9fACU @ResBioscience @BioTimeBTX @Q2Solutions @HorizonGenomics @Hologic

[ResolutionBio @ResBioscience]

Happy to announce the publication of our ctDNA paper with @DanaFarber http://t.co/qe9pVSNGTc #liquidbiopsy #lungcancer

[ResolutionBio @ResBioscience]

@TheALCF found 75% of patients in the Young Lung Cancer had actionable mutations. http://t.co/MfIwndl2fd

[ResolutionBio @ResBioscience]

ALCMI fun run against lung cancer

[ResolutionBio @ResBioscience]

Great fun run! @bonniejaddario @IASLC #wlic2015 #beatlungcancer